Stocktoria
Genus plc GNS.L
GB · London Stock Exchange · XLON · stock · Healthcare · website
Genus plc financials (annual)
Bars are annual figures from 2023 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | £658.1M | £672.8M | £668.8M | £689.7M |
| Gross profit | £244.8M | — | £178.7M | £187.5M |
| R&D expense | £19.3M | — | £27.8M | £31.0M |
| SG&A expense | £122.9M | — | £109.1M | £103.6M |
| Operating income | £90.8M | £50.2M | £6.4M | £44.0M |
| Interest expense | £15.8M | £20.5M | £21.3M | £14.3M |
| Income tax | £25.0M | — | £3.1M | £7.6M |
| Net income | £285.3M | £19.3M | £7.9M | £33.3M |
| EPS (diluted) | £4.25 | £0.25 | £0.12 | £0.50 |
| Operating cash flow | £74.4M | £67.2M | £29.8M | £50.4M |
| Free cash flow | £56.3M | £48.6M | £5.1M | £15.2M |
| Cash & equivalents | £43.7M | £48.0M | £42.5M | £36.3M |
| Inventory | £83.7M | £80.9M | £89.4M | £85.1M |
| Goodwill | £103.4M | £102.8M | £110.3M | £107.8M |
| Total assets | £1.0B | £899.0M | £987.8M | £966.4M |
| Total debt | £107.5M | £265.9M | £291.2M | £232.1M |
| Total liabilities | £251.6M | £423.0M | £474.3M | £429.6M |
| Shareholders' equity | £766.7M | £475.6M | £517.8M | £544.5M |
Growth · year-over-year · Revenue CAGR -1.6%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue growth | -2.2% | +0.6% | -3.0% | — |
| Net income growth | +1378.2% | +144.3% | -76.3% | — |
| EPS growth | +1628.0% | +106.7% | -76.4% | — |
| Free cash flow growth | +15.8% | +852.9% | -66.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · GB · as of 2025-06-30. Figures in GBP. Facts plus Stocktoria's own computed scores — not investment advice.